Division of Cardiac Surgery, University of Ottawa Heart Institute, Ottawa, Canada;
Ann Cardiothorac Surg. 2013 Jan;2(1):3-9. doi: 10.3978/j.issn.2225-319X.2013.01.07.
Aortic valve repair has emerged as a feasible alternative to replacement in the surgical treatment of selected patients with aortic valve (AV) pathology. In order to provide a synopsis of the current literature, we preformed a systematic review with a focus on valve-related events following AV repair.
Structured keyword searches of Embase and PubMed were performed in January 2012. A study was eligible for inclusion if it reported early mortality, late mortality, or valve-related morbidity in the adult population.
Initial search results identified 3,507 unique studies. After applying inclusion and exclusion criteria, 111 studies remained for full-text review. Of these, 17 studies involving 2,891 patients were included for quantitative assessment. No randomized trials were identified. Tricuspid and bicuspid AV pathologies were present in 65% (range, 21-100%) and 13.5% (range, 5-100%) of the population, respectively. Cusp repair techniques were applied in a median of 46% (range, 5-100%) of patients. The median requirement for early reoperation for post-operative bleeding and early reintervention for primary AV repair failure was 3% (range, 0-10%) and 2% (range, 0-16%), respectively. Pooled early mortality was 2.6% (95% CI: 1.4-4.4%, I(2) =0%). Late mortality and valve-related events were linearized [(number of events/number of patient-years) ×100] (%/pt-yr) for each study. Late operated valve endocarditis was reported at median event rate of 0.23%/pt-yr (range, 0-0.78%/pt-yr), while a composite outcome of neurological events and thromboembolism occurred at a median rate of 0.52%/pt-yr (0-0.95%/pt-yr). Late AV re-intervention requiring AV replacement or re-repair occurred at a rate of 2.4%/pt-yr (range, 0-4.2%/pt-yr). The median 5-year freedom from AV re-intervention and late recurrent aortic insufficiency >2+ estimated from survival curves was 92% (range, 87-98%) and 88% (range, 87-100%), respectively. Pooled late mortality produced summary estimate of 1.3%/pt-yr (95% CI: 0.9-2.1%, I(2) =0%).
The present systematic review confirmed the low operative risk of patients who underwent aortic valve preservation and repair. There is a need for long-term follow-up studies with meticulous reporting of outcomes following AV repair, as well as comparative studies with aortic valve replacement.
主动脉瓣修复已成为一种可行的替代方案,用于治疗特定的主动脉瓣(AV)病变患者的手术治疗。为了提供当前文献的概述,我们进行了系统评价,重点是 AV 修复后的瓣膜相关事件。
2012 年 1 月对 Embase 和 PubMed 进行了结构化关键词搜索。如果研究报告了成年人群体的早期死亡率、晚期死亡率或瓣膜相关发病率,则符合纳入标准。
最初的搜索结果确定了 3507 项独特的研究。在应用纳入和排除标准后,111 项研究仍需进行全文审查。其中,17 项涉及 2891 名患者的研究被纳入定量评估。未确定随机试验。三尖瓣和二叶式 AV 病变分别存在于 65%(范围,21-100%)和 13.5%(范围,5-100%)的人群中。瓣叶修复技术在中位数为 46%(范围,5-100%)的患者中应用。早期因术后出血再次手术和原发性 AV 修复失败而再次干预的中位需求分别为 3%(范围,0-10%)和 2%(范围,0-16%)。总体早期死亡率为 2.6%(95%CI:1.4-4.4%,I²=0%)。晚期死亡率和瓣膜相关事件以每个研究的线性化[(事件数/患者年数)×100](%/pt-yr)表示。晚期手术性心内膜炎的报告发生率中位数为 0.23%/pt-yr(范围,0-0.78%/pt-yr),而神经事件和血栓栓塞的复合结局发生率中位数为 0.52%/pt-yr(0-0.95%/pt-yr)。需要再次进行 AV 置换或再次修复的晚期 AV 再介入的发生率为 2.4%/pt-yr(范围,0-4.2%/pt-yr)。从生存曲线得出的 5 年 AV 再介入和晚期复发性主动脉瓣关闭不全>2+的无事件生存率中位数分别为 92%(范围,87-98%)和 88%(范围,87-100%)。汇总后的晚期死亡率产生了 1.3%/pt-yr(95%CI:0.9-2.1%,I²=0%)的汇总估计值。
本系统评价证实了接受主动脉瓣保护和修复的患者手术风险较低。需要进行长期随访研究,对 AV 修复后的结果进行细致报告,以及与主动脉瓣置换进行比较研究。